1996
DOI: 10.1016/s0022-5347(01)65584-8
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Estrogens Only on the Prostates of Aging Men

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
1

Year Published

1998
1998
2012
2012

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(17 citation statements)
references
References 15 publications
0
16
1
Order By: Relevance
“…Even more surprising in this setting is the strong expression of androgen receptor, which is in contrast with a report fi nding few androgen but ample estrogen and progesterone receptors detectable in the stroma and epithelium of the (small) prostate of aging male transsexuals [2] . In those patients, biopsies showed PSA expression in most cases.…”
Section: Discussioncontrasting
confidence: 58%
“…Even more surprising in this setting is the strong expression of androgen receptor, which is in contrast with a report fi nding few androgen but ample estrogen and progesterone receptors detectable in the stroma and epithelium of the (small) prostate of aging male transsexuals [2] . In those patients, biopsies showed PSA expression in most cases.…”
Section: Discussioncontrasting
confidence: 58%
“…the authors are grateful to Aging Today for extending their permission to cite copyrighted articles. van Kesteren et al (1996) Study and control groups, …”
Section: Resultsmentioning
confidence: 99%
“…Related themes included the dearth of educated health, mental health, and social care professionals (including the lack of geriatric care specialists who are familiar with trans physiology) (Berreth, 2003;Blank et al, 2009;Cook-Daniels, 2008a;Witten, 2002b); the denial of insurance coverage for trans-specific health care issues (Minter, 2002;Williams & Freeman, 2007;Witten & Eyler, 2006); the failure of care providers to differentiate trans issues from other health care issues and, by extension, the denial of insurance coverage for non-trans-specific health care issues (Berreth, 2003;Blank et al, 2009;Cook-Daniels, 2006;Haber, 2009;Knochel, 2011;OPHA, 2004;Williams & Freeman, 2007;Witten, 2003a;Witten & Eyler, 2006;Witten & Whittle, 2004); and, with minor exceptions, the lack of knowledge vis-à-vis the relationship between aging and gender transition (Berreth, 2003;Blank et al, 2009;Ferron, Young, Boulanger, Rodriguez, & Moreno, 2010;Haber, 2009;OPHA, 2004;Persson, 2009;Williams & Freeman, 2007;Witten, 2002b;Witten & Eyler, 2006;Witten & Whittle, 2004). Exceptions included articles exploring the long-term risks of contragender hormone use on bone density and prostate health (Mueller et al, 2005;van Kesteren et al, 1996;Witten & Eyler, 2007), and those exploring the impact of hormone treatment on hormone-related tumors (Mueller & Gooren, 2008;Persson, 2009). …”
Section: Health and Mental Healthmentioning
confidence: 99%
“…In studies examining the role of estrogens in BPH development, it was proved that injecting DHT and estrogen together into castrated dogs caused prostatic hyperplasia, that DHT and estrogen had a synergistic effect with androgens, and that DHT and estrogen caused an increase in sensitization of the prostate to androgens by stimulating intraprostatic androgen receptor concentration [3,16,17]. However, estrogens without androgens cause prostatic shrinkage, instead of benign prostatic hyperplasia [18]. Positive correlation between BPH volume and levels of free testosterone, estradiol, and estriol is indication of the synergistic effect of estrogens and androgens in BPH development [1].…”
Section: Discussionmentioning
confidence: 99%